These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28231812)

  • 21. Macrolide and lincosamide resistance of Streptococcus agalactiae in pregnant women in Poland.
    Kamińska D; Ratajczak M; Nowak-Malczewska DM; Karolak JA; Kwaśniewski M; Szumala-Kakol A; Dlugaszewska J; Gajecka M
    Sci Rep; 2024 Feb; 14(1):3877. PubMed ID: 38366099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.
    Yao W; Xu G; Li D; Bai B; Wang H; Cheng H; Zheng J; Sun X; Lin Z; Deng Q; Yu Z
    BMC Infect Dis; 2019 Feb; 19(1):175. PubMed ID: 30782125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The new macrolide-lincosamide-streptogramin B resistance gene erm(45) is located within a genomic island in Staphylococcus fleurettii.
    Wipf JR; Schwendener S; Nielsen JB; Westh H; Perreten V
    Antimicrob Agents Chemother; 2015; 59(6):3578-81. PubMed ID: 25779586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.
    Green M; Martin JM; Barbadora KA; Beall B; Wald ER
    Antimicrob Agents Chemother; 2004 Feb; 48(2):473-6. PubMed ID: 14742197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.
    Silva-Costa C; Ramirez M; Melo-Cristino J;
    J Antimicrob Chemother; 2015 Oct; 70(10):2729-33. PubMed ID: 26142474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
    Acikgoz ZC; Gocer S; Tuncer S
    J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrolide, lincosamide, and streptogramin B resistance in lipophilic Corynebacteria inhabiting healthy human skin.
    Szemraj M; Kwaszewska A; Pawlak R; Szewczyk EM
    Microb Drug Resist; 2014 Oct; 20(5):404-9. PubMed ID: 24735183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.
    Silva-Costa C; Pinto FR; Ramirez M; Melo-Cristino J;
    Clin Microbiol Infect; 2008 Dec; 14(12):1152-9. PubMed ID: 19046174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.
    Green M; Allen C; Bradley J; Dashefsky B; Gilsdorf JR; Marcon MJ; Schutze GE; Smith C; Walter E; Martin JM; Edwards KA; Barbadora KA; Rumbaugh RM; Wald ER
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2487-9. PubMed ID: 15917551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents.
    Mendes RE; Castanheira M; Farrell DJ; Flamm RK; Sader HS; Jones RN
    J Glob Antimicrob Resist; 2017 Mar; 8():28-32. PubMed ID: 27939809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
    J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tn5406, a staphylococcal transposon associated with macrolide-lincosamide-streptogramin
    Deshamukhya C; Bhowmik D; Dhar Chanda D; Bhattacharjee A
    Indian J Med Microbiol; 2023; 42():30-33. PubMed ID: 36967212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
    Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
    Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
    Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
    J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis.
    Juda M; Chudzik-Rzad B; Malm A
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):155-60. PubMed ID: 27008373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan.
    Huang CY; Lai JF; Huang IW; Chen PC; Wang HY; Shiau YR; Cheng YW; Hsieh LY; Chang SC; Lauderdale TL
    J Clin Microbiol; 2014 Feb; 52(2):508-16. PubMed ID: 24478481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility pattern of β-haemolytic group A, C and G streptococci isolated from North India.
    Dhanda V; Chaudhary P; Toor D; Kumar R; Chakraborti A
    J Med Microbiol; 2013 Mar; 62(Pt 3):386-393. PubMed ID: 23139395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)].
    Campelo FA; Pedrosa AC; Antúnez IÁ; Capuz BL
    Rev Esp Quimioter; 2012 Mar; 25(1):42-6. PubMed ID: 22488541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resistance to macrolides in the species Streptococcus pyogenes in the Czech Republic in 1996-2003].
    Urbásková P; Jakubů V;
    Epidemiol Mikrobiol Imunol; 2004 Nov; 53(4):196-202. PubMed ID: 15633541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.